IMMOBILISATION PROLONGED

This adverse event was reported 122 times

These drugs are most commonly taken by patients reporting IMMOBILISATION PROLONGED:

# Drug Count
0 ZOLPIDEM TARTRATE 21
1 DIAZEPAM 20
2 DIAZEPAM ORAL 19
3 DIAZEPAM ORAL SOLUTION (CONCENTRATE) 19
4 ALPRAZOLAM 15
5 ESCITALOPRAM 11
6 INSULIN GLARGINE 11
7 ESCITALOPRAM OXALATE 10
8 ESCITSLOPRAM 9
9 ESOMEPRAZOLE MAGNESIUM 9
See all common drugs associated with IMMOBILISATION PROLONGED

IMMOBILISATION PROLONGED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 GALANTAMINE 2 0.0012
1 2%MENTHOL 1 0.0010
2 COUGH SUPPRESSANT 1 0.0010
3 INTERFERON GAMMA-1B 1 0.0007
4 POTASSIUM ACETATE 1 0.0007
5 ANIDULAFUNGIN 1 0.0006
6 CEFADROXIL 1 0.0005
7 BREXUCABTAGENE AUTOLEUCEL 1 0.0005
8 SILVER SULFADIAZINE 1 0.0004
9 AMPICILLIN SODIUM AND SULBACTAM SODIUM 1 0.0004
See all drugs enriched for association with IMMOBILISATION PROLONGED